Skip to Content
Søk Menu

Ny MEDcast-serie

I 2022 lanserer BestPractice Nordic en ny MEDcast-serie i Norge med fokus på onkologi og hematologi. Her vil du hver måned kunne høre en ny episode hvor to eksperter, med utgangspunkt i en case, diskuterer utfordringer og behandlingsmuligheter ved forskjellige diagnoser.

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Relatert innhold

Significant improvements in OS and RFS for older patients with AML

/ Farhad Ravandi
AMLEHA21 Play the Video 6:03

Iberdomide show promising efficacy in heavily pretreated patients with Relapsed/Refractory Multiple Myeloma

/ Sagar Lonial
EHA21Myelomatose Play the Video 7:04

Highlights EHA 2021 (2:2)

/ Agoston Gyula Szabos
EHA21 Play the Video 15:27

Highlights EHA 2021 (1:2)

/ Agoston Gyula Szabos / Fredrik Schjesvold
EHA21 Play the Video 30:30

EHA-ESMO Clinical Practice Guidelines for Multiple Myeloma

/ Fredrik Schjesvold
EHA21Myelomatose Play the Video 14:09

Potential to become the best treatment for multiple myeloma in history

/ Thierry Facon
EHA21Myelomatose Play the Video 16.14

New bispecific antibody with promising efficacy and safety profil for patients with relapsed/refractory Multiple Myeloma

/ Amrita Y. Krishnan
EHA21Myelomatose Play the Video 4:09

First-in-human study of teclistamab for relapsed/refractory Multiple Myeloma

/ Niels van de Donk
EHA21Myelomatose Play the Video 10:26

Early responses for BCMA-directed CAR-T cell therapy in progressive MM after 1-3 prior lines of therapy

/ Mounzer Agha
EHA21Myelomatose Play the Video 13:33
Back to top